Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04022746 · ClinicalTrials.gov registry record · NA

An Investigational Scan (Magnetic Resonance Elastography) in Detecting Treatment Response in Patients With Advanced Liver Cancer

A NA study, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
NA
Development phase
6
Enrollment target

NCT04022746: Completed NA study, sponsored by M.D. Anderson Cancer Center.

NCT04022746 is a NA study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04022746, a NA study, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

This trial studies how well an investigational scan (magnetic resonance elastography \[MRE\]) works with standard imaging (magnetic resonance imaging \[MRI\]) in detecting response to treatment in patients with liver cancer that has spread to other places in the body. Diagnostic procedures, such as MRE with MRI, may make it easier for researchers to see if the treatment for liver cancer is working.

Primary Outcome

Imaging measurements and percent necrosis will be summarized using mean, standard deviation (SD), and range. Pearson correlation coefficient will be estimated between imaging measurements and percent necrosis.

Interventions

  • PROCEDURE Magnetic Resonance Imaging
  • PROCEDURE Magnetic Resonance Elastography

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2019-06-11
Est. Completion 2025-02-13
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT04022746 record still lists

NCT04022746 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 2 interventions - of which Magnetic Resonance Imaging is the first listed.

NCT04022746 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04022746 about?

NCT04022746 is a clinical study titled "An Investigational Scan (Magnetic Resonance Elastography) in Detecting Treatment Response in Patients With Advanced Liver Cancer". This trial studies how well an investigational scan (magnetic resonance elastography \[MRE\]) works with standard imaging (magnetic resonance imaging \[MRI\]) in detecting response to treatment in patients with liver cancer that has spread to other places in the body. Diagnostic procedures, such as ...

What is the current status of trial NCT04022746?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2019-06-11. Estimated completion is 2025-02-13.

What interventions are being tested in trial NCT04022746?

The interventions under investigation include: Magnetic Resonance Imaging (PROCEDURE), Magnetic Resonance Elastography (PROCEDURE).

Who is sponsoring clinical trial NCT04022746?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04022746's enrollment target sits among peer trials

6 1983rd of 2000 higher than 13 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04022746, the US trial registry maintained by the National Library of Medicine. NCT04022746 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.